definiens: shall mean all Informati on and Material Controlled by [COMPANY] on or following the Effective Date necessary to Develop, manufacture or Commercialize Cell Therapy Products, Collaboration Products or Unoptioned Cell Therapy Products, including but not limited to the following information : ( 1 ) information disclosed in an IND for SCF and/or Flt3 -L as of the Effective Date ; ( 2 ) information disclosed as of the Effective Date in any IND supplements for SCF and/or Flt3 - L ; ( 3 ) all [COMPANY] - sponsored collabor ator data and results ( subject to any contractual confidentiality obligat ions of [COMPANY] to Third Parties regarding such results ) that [COMPANY] elects t o and does provide to [COMPANY] ; ( 4 ) any regulatory data that [COMPANY] elects to and does provide to [COMPANY] ; ( 5 ) sequence information or other technica l information and trade secrets relating to any [COMPANY] Materials and informa tion regarding their structure, function and activity that [COMPANY] elects to and does provide to [COMPANY] ; and ( 6 ) such other information that [COMPANY] elects to and does disclose to [COMPANY], in each case that [COMPANY] expressly desig nates in writing as or or that it otherwis e designates as [COMPANY] Know - How under this Agreement ; provided however, th at [COMPANY] Know - How shall exclude Joint Know - How